Turn Therapeutics (TTRX) Earnings Analysis

Turn Therapeutics (TTRX) next reports earnings on 2026-08-10, consensus EPS -0.03 USD. Last quarter (2026-05-11) it missed with EPS -0.03 USD vs -0.02 USD est (-50%). It has beaten estimates in 0/2 recent quarters (0%). Trailing P/E -52.94.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does TTRX next report earnings?

Next earnings date2026-08-10
Consensus EPS estimate-0.03 USD
Revenue estimaten/a

TTRX earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-05-11-0.03 USD-0.02 USD-50%Miss
2026-03-31-0.09 USD-0.051 USD-76.5%Miss
2025-11-13-0.07 USDn/an/an/a

Beat rate: 0/2 (0%) over reported quarters with consensus data.

TTRX valuation and analyst view

Trailing P/E-52.94
Trailing EPS-0.13016 USD
Price / book46.35
Dividend yield0.00%
Market cap0.30B
Analyst consensusBuy (1 buy / 0 hold / 0 sell)

Related research pages

Frequently asked questions

When is Turn Therapeutics (TTRX)'s next earnings date?

Turn Therapeutics is next scheduled to report on 2026-08-10, with a consensus EPS estimate of -0.03 USD.

Did TTRX beat earnings last quarter?

In its 2026-05-11 report, TTRX posted EPS of -0.03 USD versus a -0.02 USD estimate — a miss of 50%.

What is TTRX's earnings track record?

Over the last 2 reported quarters with consensus data, TTRX beat estimates 0 times (0%).

What is TTRX's current P/E ratio and EPS?

TTRX trades at a trailing P/E of -52.94 on trailing EPS of -0.130156771610802 USD.

What do analysts rate TTRX?

Analyst consensus is "Buy" across 1 ratings (0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell).